CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Investors use market indices for benchmarking, asset allocation, and risk management, enabling efficient, cost-effective exposure to markets.
27,738 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
A researcher from Apex Crypto argues XRP’s flat price path reflects more than market dynamics, pointing to Citibank d...
NVIDIA shares pulled back amid an AI sector-wide retreat, but a growing data-center footprint and a record order book...
Google has rolled out home listings in mobile search across all 50 states, creating a nationwide data channel for MLS...
As AI excitement cools, investors parse the shift from trade short-term bets to a lasting investment decade. BlackRoc...
XRP trades near $1.28 as traders look to a pivotal $1.30 hurdle this week. Analysts weigh bullish breakouts against p...
Andrew Tate has reopened a sizable bitcoin long amid a broader crypto rally. On-chain trackers show a 57.36 BTC posit...
Regulators shut down a high-profile crypto executive, imposing a permanent trading ban. The move sends a clear messag...
Alphabet signals a strategic pivot as enterprise AI becomes the main growth driver. Google Cloud surges, and a massiv...
GLDI payouts climbed to 4.43 in May 2026, appealing to retirees seeking steady gold exposure. Yet thinner option prem...
This international recap dives into how June political headlines and tech softness have weighed on key markets. Learn...
Meta is pursuing prediction markets, signaling a major shift away from its metaverse push. The move could reshape its...